Darwin Knows

Mabion SA

Darwin Score	+5
Ticker	MAB
Latest Price	9.93 PLN as of close on 04-Jul-2025
3 Month price range	9.13 to 11.50 PLN
Market Capitalisation	159.68Mn PLN
Country	Poland
Region	Europe
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. Mabion S.A. was founded in 2007 and is based in Konstantynów Lódzki, Poland. See More ...
Company URL	https://www.mabion.eu

See Darwins Full Analysis for Mabion SA

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Mabion SA. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+6
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	0
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	-1

Alerts

There are 1 live alerts for Mabion SA. All the alerts are negative.

The 50d moving average turned downwards 5 days ago. (Negative)

To see complete information on Mabion SA or any other assets please login.

If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.